Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Robotics: Corindus, Hansen Pursue Vascular Cath Lab Indications

This article was originally published in The Gray Sheet

Executive Summary

Robot-assisted surgery has generated excitement in recent years, but one high-volume procedure category where robotic equipment has yet to play a significant role is angioplasty and stenting.

You may also be interested in...



Robot-Assisted PCI: Corindus Plans Gradual Launch For Newly Cleared System

The company announced 510(k) clearance of its CorPath 200 System July 25, calling it the “first and only” robot-assisted tool that allows percutaneous coronary interventions to be performed from an interventional cockpit.

Hansen Plans Slow Start For Newly Cleared Magellan Robot

The device maker plans a slow rollout for its first-in-class robotic system, which allows physicians to perform peripheral vascular procedures, including angioplasty and stenting, from a remote workstation.

Research In Brief

Data updates from HRS, SCAI meetings, and more.

Related Content

Topics

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel